• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Alkem Laboratories Ltd.
    03 Jun 2025
    Analyst Buy
    5580.50
    0.65%
    Alkem Promoter Jayanti Sinha To Sell 1.42% Stake Via Block Deal
    Alkem Promoter Jayanti Sinha To Sell 1.42% Stake Via Block Deal
    NDTV Profit
    The floor price for the shares has been set at Rs 4,850 apiece, a discount of about 3% to Alkem's current market price.
    Copy LinkShare onShare on Share on Share on
    Alkem Laboratories L.. has an average target of 5463.50 from 2 brokers.
    logo
    Indoco Remedies Ltd.
    03 Jun 2025
    303.65
    0.58%
    Indoco Remedies Subsidiary Launches Generic Drug In UK
    Indoco Remedies Subsidiary Launches Generic Drug In UK
    NDTV Profit
    This significant addition to Indo Remedies portfolio will be marketed and distributed by Clarity Pharma across the UK, it added.
    Copy LinkShare onShare on Share on Share on
    Indoco Remedies Ltd. is trading above all available SMAs
    logo
    Dr. Reddy's Laboratories Ltd.
    02 Jun 2025
    1297.70
    -0.82%
    A test case' unfolds over Novo Nordisk's weight loss and diabetes drug semaglutide
    Business Line
    Novo Nordisk is locked in a patent infringement battle with Dr Reddy's Laboratories and OneSource Specialty Pharma
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
    logo
    AstraZeneca Pharma India Ltd.
    02 Jun 2025
    8812.50
    0.59%
    AstraZeneca Pharma shares surge 12% after Q4 results; profit jumps 48%
    Business Standard
    AstraZeneca Pharma India rallied nearly 12 per cent after its net profit for the fourth quarter of the previous financial year jumped 48 per cent
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd.'s price crossed below 50Day SMA today
    AstraZeneca Pharma India Share Price Jumps Post Q4 Profit, Margin Growth
    NDTV Profit | 02 Jun 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    02 Jun 2025
    1629.00
    -0.13%
    New launches to drive Sun Pharma's future growth; PAT may take a hit by tax surge
    New launches to drive Sun Pharma's future growth; PAT may take a hit by tax surge
    Economic Times
    Sun Pharma anticipates revenue growth for fiscal year 26, building on an 8% increase in fiscal year 25. However, increased spending on marketing specialty products may impact profitability. Net profit declined in the March quarter due to higher taxes. The company plans to launch new drugs like Leqselvi and Unloxcyt.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading above its 30 day SMA of 1613.7
    Sun Pharma Lines Up $100 Million To Commercialise Niche Products This Fiscal
    NDTV Profit | 01 Jun 2025 2 more
    Sun Pharma to invest $100 mn in commercialising speciality products this fiscal
    Business Line | 01 Jun 2025
    Sun Pharma lines up $100 mn to commercialise niche products in FY26
    Business Standard | 01 Jun 2025
    logo
    Ipca Laboratories Ltd.
    01 Jun 2025
    1357.50
    -2.70%
    Ipca Labs Q4 Results Review: Dolat Capital Maintains 'Add', Revises Target Price
    Ipca Labs Q4 Results Review: Dolat Capital Maintains 'Add', Revises Target Price
    NDTV Profit
    Dolat Capital maintains Accumulate' rating at 30x FY27E P/E with a revised target price of Rs 1,604.
    Copy LinkShare onShare on Share on Share on
    Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
    logo
    Dr. Reddy's Laboratories Ltd.
    31 May 2025
    1297.70
    -0.82%
    Dr Reddy's faces 2,395 crore tax demand
    Business Line
    Disputes reassessment linked to merger under amalgamation scheme
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    Pfizer Ltd.
    31 May 2025
    4991.50
    -0.69%
    Breast cancer: Pfizer-Arvinas drug beats AstraZeneca's in delaying disease's progression
    Business Line
    Trial finds Pfizer and Arvinas' experimental drug vepdegestrant increases survival without progression of breast cancer in patients with ESR1 mutations by five months
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 129 to 139 in Jun 2025 qtr.
    logo
    AstraZeneca Pharma India Ltd.
    30 May 2025
    8812.50
    0.59%
    AstraZeneca Pharma Q4 FY25 net profit jumps 48% to Rs 58.25 crore
    Business Standard
    Q4 net profit rises 48% to Rs 58.25 crore; revenue up 25.3% on strong growth across therapeutic areas, with oncology revenue up over 31% and record full-year sales
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. has gained 30.59% in the last 1 Year
    AstraZeneca Pharma rises 2% on securing CDSCO nod for Benralizumab solution
    Business Standard | 30 May 2025
    logo
    Natco Pharma Ltd.
    30 May 2025
    853.40
    -0.25%
    Natco Pharma Q4 Results Review: Dolat Capital Maintains 'Sell', Sees 11% Downside
    Natco Pharma Q4 Results Review: Dolat Capital Maintains 'Sell', Sees 11% Downside
    NDTV Profit
    Dolat Capital maintains Sell' rating with a revised target price of Rs772 at 28x FY27E P/E.
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd. has lost -40.75% in the last 1 Year
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Atlanta Electricals
    • True Colors
    • Aptus Pharma
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd